ICH
ICH Q7 19.25
19. AGENTS, BROKERS, TRADERS, DISTRIBUTORS, REPACKERS, AND RELABELLERS
Section text
Labelling for APIs intended for use in clinical trials should be appropriately controlled and should identify the material as being for investigational use.
Source: International Council for Harmonisation (ICH) · © ICH. Per the legal notice in each guideline, the document may be used, reproduced and distributed provided ICH's copyright is acknowledged; any adaptation or translation must be labelled as such and must not imply ICH endorsement. · retrieved 2026-11-15